71 related articles for article (PubMed ID: 21890007)
1. Effects of Clostridium difficile Toxin A on the proteome of colonocytes studied by differential 2D electrophoresis.
Zeiser JJ; Klodmann J; Braun HP; Gerhard R; Just I; Pich A
J Proteomics; 2011 Dec; 75(2):469-79. PubMed ID: 21890007
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
Zeiser J; Gerhard R; Just I; Pich A
J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
[TBL] [Abstract][Full Text] [Related]
3. Time-resolved cellular effects induced by TcdA from Clostridium difficile.
Jochim N; Gerhard R; Just I; Pich A
Rapid Commun Mass Spectrom; 2014 May; 28(10):1089-100. PubMed ID: 24711272
[TBL] [Abstract][Full Text] [Related]
4. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
5. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
7. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells.
Gerhard R; Nottrott S; Schoentaube J; Tatge H; Olling A; Just I
J Med Microbiol; 2008 Jun; 57(Pt 6):765-770. PubMed ID: 18480335
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile toxins A and B directly stimulate human mast cells.
Meyer GK; Neetz A; Brandes G; Tsikas D; Butterfield JH; Just I; Gerhard R
Infect Immun; 2007 Aug; 75(8):3868-76. PubMed ID: 17517880
[TBL] [Abstract][Full Text] [Related]
9. Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.
Kreimeyer I; Euler F; Marckscheffel A; Tatge H; Pich A; Olling A; Schwarz J; Just I; Gerhard R
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):253-62. PubMed ID: 21046073
[TBL] [Abstract][Full Text] [Related]
10. Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
Schoentaube J; Olling A; Tatge H; Just I; Gerhard R
Cell Microbiol; 2009 Dec; 11(12):1816-26. PubMed ID: 19709124
[TBL] [Abstract][Full Text] [Related]
11. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile toxin B inhibits the secretory response of human mast cell line-1 (HMC-1) cells stimulated with high free-Ca²⁺ and GTPγS.
Balletta A; Lorenz D; Rummel A; Gerhard R; Bigalke H; Wegner F
Toxicology; 2015 Feb; 328():48-56. PubMed ID: 25497110
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
[TBL] [Abstract][Full Text] [Related]
14. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
Antunes A; Dupuy B
Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
[TBL] [Abstract][Full Text] [Related]
15. Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and B.
Frädrich C; Beer LA; Gerhard R
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26797634
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
[TBL] [Abstract][Full Text] [Related]
17. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
Persson S; Torpdahl M; Olsen KE
Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases.
Nottrott S; Schoentaube J; Genth H; Just I; Gerhard R
Apoptosis; 2007 Aug; 12(8):1443-53. PubMed ID: 17437185
[TBL] [Abstract][Full Text] [Related]
19. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
20. Haemorrhagic toxin and lethal toxin from Clostridium sordellii strain vpi9048: molecular characterization and comparative analysis of substrate specificity of the large clostridial glucosylating toxins.
Genth H; Pauillac S; Schelle I; Bouvet P; Bouchier C; Varela-Chavez C; Just I; Popoff MR
Cell Microbiol; 2014 Nov; 16(11):1706-21. PubMed ID: 24905543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
